Altered Selectivity of Parathyroid Hormone (PTH) and PTH-Related Protein (PTHrP) for Distinct Conformations of the PTH/PTHrP Receptor
Open Access
- 1 January 2008
- journal article
- other
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 22 (1) , 156-166
- https://doi.org/10.1210/me.2007-0274
Abstract
PTH and PTHrP use the same G protein-coupled receptor, the PTH/PTHrP receptor (PTHR), to mediate their distinct biological actions. The extent to which the mechanisms by which the two ligands bind to the PTHR differ is unclear. We examined this question using several pharmacological and biophysical approaches. Kinetic dissociation and equilibrium binding assays revealed that the binding of [125I]PTHrP(1–36) to the PTHR was more sensitive to GTPγS (added to functionally uncouple PTHR-G protein complexes) than was the binding of [125I]PTH(1–34) (∼75% maximal inhibition vs. ∼20%). Fluorescence resonance energy transfer-based kinetic analyses revealed that PTHrP(1–36) bound to the PTHR more slowly and dissociated from it more rapidly than did PTH(1–34). The cAMP signaling response capacity of PTHrP(1–36) in cells decayed more rapidly than did that of PTH(1–34) (t1/2 = ∼1 vs. ∼2 h). Divergent residue 5 in the ligand, Ile in PTH and His in PTHrP, was identified as a key determinant of the altered receptor-interaction responses exhibited by the two peptides. We conclude that whereas PTH and PTHrP bind similarly to the G protein-coupled PTHR conformation (RG), PTH has a greater capacity to bind to the G protein-uncoupled conformation (R0) and, hence, can produce cumulatively greater signaling responses (via R0→RG isomerization) than can PTHrP. Such conformational selectivity may relate to the distinct modes by which PTH and PTHrP act biologically, endocrine vs. paracrine, and may help explain reported differences in the effects that the ligands have on calcium and bone metabolism when administered to humans.Keywords
This publication has 39 references indexed in Scilit:
- Role of Amino Acid Side Chains in Region 17–31 of Parathyroid Hormone (PTH) in Binding to the PTH ReceptorJournal of Biological Chemistry, 2006
- Teriparatide [Human PTH(1-34)]: 2.5 Years of Experience on the Use and Safety of the Drug for the Treatment of OsteoporosisJournal of Bone and Mineral Research, 2006
- The Mid-Region of Parathyroid Hormone (1−34) Serves as a Functional Docking Domain in Receptor ActivationBiochemistry, 2006
- Initial Characterization of PTH-Related Protein Gene-Driven lacZ Expression in the MouseJournal of Bone and Mineral Research, 2006
- Novel Parathyroid Hormone (PTH) Antagonists That Bind to the Juxtamembrane Portion of the PTH/PTH-related Protein ReceptorJournal of Biological Chemistry, 2005
- Parathyroid hormone and parathyroid hormone-related peptide, and their receptorsBiochemical and Biophysical Research Communications, 2004
- Selective Ligand-induced Stabilization of Active and Desensitized Parathyroid Hormone Type 1 Receptor ConformationsPublished by Elsevier ,2002
- A Highly Effective Dominant Negative αs Construct Containing Mutations That Affect Distinct Functions Inhibits Multiple Gs-coupled Receptor Signaling PathwaysJournal of Biological Chemistry, 2002
- Parathyroid Hormone (PTH)-(1–14) and -(1–11) Analogs Conformationally Constrained by α-Aminoisobutyric Acid Mediate Full Agonist Responses via the Juxtamembrane Region of the PTH-1 ReceptorJournal of Biological Chemistry, 2001
- Evaluating the Signal Transduction Mechanism of the Parathyroid Hormone 1 ReceptorJournal of Biological Chemistry, 2001